Synthesis and evaluation of novel fluorinated hematoporphyrin ether derivatives for photodynamic therapy

Man-Yi Li,Ying-Hua Gao,Jia-Hui Zhang,Le Mi,Xue-Xue Zhu,Feng Wang,Xing-Ping Zhou,Yi-Jia Yan,Zhi-Long Chen
DOI: https://doi.org/10.1016/j.bioorg.2020.104528
IF: 5.307
2021-02-01
Bioorganic Chemistry
Abstract:<p>A photosensitizer with high phototoxicity, suitable amphipathy and low dark toxicity could play a pivotal role in photodynamic therapy (PDT). In this study, a facile and versatile approach was adopted to synthesize a series of novel fluorinated hematoporphyrin ether derivatives (<strong>I<sub>1</sub></strong>-<strong>I<sub>5</sub></strong> and <strong>II<sub>1</sub></strong>-<strong>II<sub>4</sub></strong>), and the photodynamic activities of these compounds were studied. Compared to hematoporphyrin monomethyl ether (HMME), all PSs showed preferable photodynamic activity against A549 lung tumor cells. The longest visible absorption wavelength of these compounds was approximately 622 nm. Among them, <strong>II<sub>3</sub></strong> revealed the highest singlet oxygen yield (0.0957 min<sup>-1</sup>), the strongest phototoxicity (IC<sub>50</sub>=1.24 μM), the lowest dark toxicity <em>in vitro</em>, and exhibited excellent anti-tumor effects <em>in vivo</em>. So compound <strong>II<sub>3</sub></strong> could act as new drug candidate for photodynamic therapy.</p>
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?